Women managed with fertility-sparing treatment for gynecologic cancers face an increased risk of miscarriage

@inproceedings{Letourneau2013WomenMW,
  title={Women managed with fertility-sparing treatment for gynecologic cancers face an increased risk of miscarriage},
  author={Jacynthe Letourneau and June Maylin Chan and W H Salem and S.-w. Chan and Marcelle I. Cedars and Mitch P. Rosen},
  year={2013}
}
OBJECTIVE: To determine whether serum b-hCG assays on cycle day (CD) 24 and 26 can be used to predict IVF pregnancy outcome. DESIGN: Retrospective cohort. MATERIALS AND METHODS: All IVF patients were scheduled for luteal blood draws on CD 24 and 26. Pregnant patients from 1/04 to 12/11 who had CD 24, 26, and 28 bloods drawn (n1⁄42571) after fresh IVF were identified. Pregnancy outcomes were compared between patients whose first positive b-hCG (>5mIU/mL) occurred on CD 24 versus 26, and between… CONTINUE READING

Similar Papers